Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
暂无分享,去创建一个
Glenn J Jaffe | Ebenezer Daniel | Cynthia A Toth | Gui-Shuang Ying | Maureen G Maguire | Sumit Sharma | Jiayan Huang | G. Ying | M. Maguire | Daniel F. Martin | C. Toth | J. Grunwald | E. Daniel | G. Jaffe | Sumit Sharma | Jiayan Huang | Juan E Grunwald | Daniel F Martin | G. Ying | Ebenezer Daniel
[1] Glenn J Jaffe,et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. , 2013, Ophthalmology.
[2] I. Mantel,et al. REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome , 2015, Retina.
[3] K. Csaky. Comparison of age-related macular degeneration treatment trial. , 2011, Insight.
[4] Sandra S Stinnett,et al. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. , 2012, Ophthalmology.
[5] Ebenezer Daniel,et al. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. , 2012, Ophthalmology.
[6] K. Freund,et al. Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluid. , 2014, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.
[7] Usha Chakravarthy,et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. , 2012, Ophthalmology.
[8] G. Ying,et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. , 2012, Ophthalmology.
[9] Christian Simader,et al. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. , 2015, Ophthalmology.
[10] Glenn J Jaffe,et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.
[11] J. Duker,et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. , 2006, Archives of ophthalmology.